Home > News > Techniques for Rapid Drug Discovery Now Focusing on Nanoscience Research
May 3rd, 2007
Techniques for Rapid Drug Discovery Now Focusing on Nanoscience Research
Ron Zuckermann, lead scientist for Lawrence Berkeley National Lab's Molecular Foundry Biological Nanostructures Facility, is taking the same techniques drug companies use to discover drugs to help nanoscientists cut the cost and shorten the time for their hunt for useful nano-compounds.
Dr. Zuckermann knows a lot about that proven drug-discovery process, dubbed combinatorial chemistry - he helped invent the process more than a decade ago. Before coming to the Molecular Foundry, Dr. Zuckermann worked for the biotechnology industry, and was one of the creators of the combinatorial chemistry techniques, whereby researchers create and test thousands (and in some cases millions) of compounds for just the right properties. His current LBNL work is sponsored by the Department of Energy, and is available for universities and private research arms to participate in.
Aculon Hires New Business Development Director December 19th, 2014
ORNL microscopy pencils patterns in polymers at the nanoscale December 17th, 2014
Pb islands in a sea of graphene magnetise the material of the future December 16th, 2014
Graphene Applied in Production of Recyclable Electrodes December 13th, 2014
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Piezoelectricity in a 2-D semiconductor: Berkeley Lab researchers discovery of piezoelectricty in molybdenum disulfide holds promise for future MEMS December 22nd, 2014
Quantum physics just got less complicated December 22nd, 2014
Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014
Universality of charge order in cuprate superconductors: Charge order has been established in another class of cuprate superconductors, highlighting the importance of the phenomenon as a general property of these high-Tc materials December 22nd, 2014